Posttreatment MRI to Predict Pathologic Complete Response of Triple-Negative Breast Cancer to Neoadjuvant Chemoimmunotherapy
Radiology · 01.07.2025 · 316 (1)
DOI: 10.1148/radiol.243824 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Radiology, erschienen am 01.07.2025. Verfasst von Toulsie Ramtohul und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Institut Curie, PSL Research University, 26 rue d'Ulm, Paris 75005, France. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Magnetic Resonance Imaging, Neoadjuvant Therapy, Immunotherapy. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Agence Nationale de la Recherche.
Abstract (Originalsprache)
Posttreatment MRI accurately predicted pathologic complete response following neoadjuvant chemoimmunotherapy in participants with early triple-negative breast cancer, demonstrating a low false-discovery rate.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Institut Curie, PSL Research University, 26 rue d'Ulm, Paris 75005, France.
- Department of Radiology, Institut Oscar Lambret, Lille, France.
- Department of Diagnostic and Theranostic Medicine - Pathology, Institut Curie, PSL Research University, Paris, France.
- Department of Surgical Oncology, Institut Curie, University of Versailles Saint-Quentin en Yvelines, Paris, France.
- INSERM U900, Statistical Methods for Precision Medicine, Institut Curie, Saint-Cloud, France.
- Department of Medical Oncology, Institut Curie Paris, PSL Research University, Paris, France.
ORCID-Profile: Toulsie Ramtohul, Derek Lollivier, Maxime Jin, Lounes Djerroudi, Thomas Gaillard, Claire Bonneau, Caroline Malhaire, Anne Vincent Salomon, François-Clément Bidard, Anne Tardivon, Audrey Maillez, Lauren Wallaert, Caroline Nhy, Luc Cabel
Förderung
- Agence Nationale de la Recherche
Zitieren
APA
Ramtohul, T., Lollivier, D., Spriet, J., Jin, M., Djerroudi, L., Gaillard, T., Bonneau, C., Loirat, D., Bello-Roufai, D., Kirova, Y., Loap, P., Malhaire, C., Vincent Salomon, A., Bidard, F. C., Tardivon, A., Maillez, A., Wallaert, L., Ceugnart, L., Nhy, C., & Cabel, L. (2025). Posttreatment MRI to Predict Pathologic Complete Response of Triple-Negative Breast Cancer to Neoadjuvant Chemoimmunotherapy. Radiology, 316(1). https://doi.org/10.1148/radiol.243824
Vancouver
Ramtohul T, Lollivier D, Spriet J, Jin M, Djerroudi L, Gaillard T, et al. Posttreatment MRI to Predict Pathologic Complete Response of Triple-Negative Breast Cancer to Neoadjuvant Chemoimmunotherapy. Radiology. 2025;316(1). doi:10.1148/radiol.243824
BibTeX
@article{Ramtohul2025,
author = {Ramtohul, Toulsie and Lollivier, Derek and Spriet, Justine and Jin, Maxime and Djerroudi, Lounes and Gaillard, Thomas and Bonneau, Claire and Loirat, Delphine and Bello-Roufai, Diana and Kirova, Youlia and Loap, Pierre and Malhaire, Caroline and Vincent Salomon, Anne and Bidard, François-Clément and Tardivon, Anne and Maillez, Audrey and Wallaert, Lauren and Ceugnart, Luc and Nhy, Caroline and Cabel, Luc},
title = {Posttreatment MRI to Predict Pathologic Complete Response of Triple-Negative Breast Cancer to Neoadjuvant Chemoimmunotherapy},
journal = {Radiology},
year = {2025},
volume = {316},
number = {1},
doi = {10.1148/radiol.243824}
}
EUVIMED